Rare Disease Trial, Not Yet Recruiting NCT07497581 Sponsor: Markus A. Landolt Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Not Yet Recruiting

NCT07497581
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

For children and adolescents:

  • The child has been diagnosed with a rare disease listed in the trial's Table 2.
  • The child is between 8 and 18 years old.
  • The child has enough knowledge of the German language to participate.
  • At least one legal guardian has signed a consent form; for adolescents aged 14 to 17, the young person also provides their own written consent.
  • The child lives at home, meaning they sleep at home more than four nights per week, including weekends.

For parents:

  • The parent's child has been diagnosed with a rare disease listed in the trial's Table 2.
  • The child is between 1 and 18 years old.
  • The parent has enough knowledge of German or English to participate.
  • A signed consent form is available.
  • Only one child in the family has a diagnosed rare disease.
  • Up to two caregivers per child may participate; a stepparent living with the child at least three nights per week, including weekends, may also be included.
  • The child lives at home, meaning they sleep at home more than four nights per week, including weekends.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

For children and adolescents:

  • The child has a rare disease that is not included in the trial's Table 2.
  • The child is under 8 or over 18 years old.
  • The child does not have sufficient knowledge of the German language.
  • A legal guardian has not provided signed consent, or, for adolescents aged 14 to 17, the young person has not provided their own written consent.
  • The child lives outside the home more than three nights per week, including weekends.
  • The child has a cognitive impairment.

For parents:

  • The parent's child has a rare disease that is not included in the trial's Table 2.
  • The child is under 1 or over 18 years old.
  • The parent does not have sufficient knowledge of either German or English.
  • A signed consent form has not been completed.
  • More than one child in the family has a diagnosed rare disease.
  • The child lives outside the home more than three nights per week, including weekends.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 44 249 63 88

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Markus A. Landolt
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 April 2031

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Child Mental Health and Health-Related Quality of Life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov